Development
PROCEPT BioRobotics Corporation
PRCT
$62.91
-$2.14-3.29%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 43.58M | 35.10M | 33.10M | 24.40M | 23.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.58M | 35.10M | 33.10M | 24.40M | 23.78M |
| Cost of Revenue | 22.33M | 16.23M | 14.68M | 11.91M | 13.10M |
| Gross Profit | 21.26M | 18.87M | 18.43M | 12.49M | 10.68M |
| SG&A Expenses | 36.32M | 32.88M | 32.44M | 30.13M | 26.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 73.14M | 60.71M | 58.73M | 52.78M | 48.82M |
| Operating Income | -29.56M | -25.61M | -25.63M | -28.38M | -25.04M |
| Income Before Tax | -27.50M | -24.62M | -25.29M | -28.48M | -28.17M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.50M | -24.62M | -25.29M | -28.48M | -28.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.50M | -24.62M | -25.29M | -28.48M | -28.17M |
| EBIT | -29.56M | -25.61M | -25.63M | -28.38M | -25.04M |
| EBITDA | -28.24M | -24.56M | -24.98M | -27.58M | -24.38M |
| EPS Basic | -0.54 | -0.51 | -0.56 | -0.63 | -0.63 |
| Normalized Basic EPS | -0.34 | -0.32 | -0.35 | -0.40 | -0.35 |
| EPS Diluted | -0.54 | -0.51 | -0.56 | -0.63 | -0.63 |
| Normalized Diluted EPS | -0.34 | -0.32 | -0.35 | -0.40 | -0.35 |
| Average Basic Shares Outstanding | 50.59M | 48.31M | 45.16M | 45.07M | 44.77M |
| Average Diluted Shares Outstanding | 50.59M | 48.31M | 45.16M | 45.07M | 44.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |